The characteristics of COVID-19 vaccine-related headache: Clues gathered from the healthcare personnel in the pandemic

Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine

(2021) Jerald Sadoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Latent class cluster analysis identified hidden headache phenotypes in COVID-19: impact of pulmonary infiltration and IL-6

(2021) Ömer Karadaş et al.   NEUROLOGICAL SCIENCES

Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19—A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium

(2021) Sherry H.-Y. Chou et al.   JAMA Network Open

Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study

(2020) David Liebowitz et al.   LANCET INFECTIOUS DISEASES

COVID‐19 is a Real Headache!

(2020) Hayrunnisa Bolay et al.   HEADACHE

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

(2020) Feng-Cai Zhu et al.   LANCET

Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis

(2020) Israel Júnior Borges do Nascimento et al.   Journal of Clinical Medicine

2017/18 and 2018/19 seasonal influenza vaccine safety surveillance, Canadian National Vaccine Safety (CANVAS) Network

(2020) Julie A Bettinger et al.   Eurosurveillance

Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: a retrospective cohort study

(2020) Javier Trigo et al.   JOURNAL OF HEADACHE AND PAIN

Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial

(2020) Milagritos D Tapia et al.   LANCET INFECTIOUS DISEASES

Headache characteristics in COVID-19 pandemic-a survey study

(2020) Özge Uygun et al.   JOURNAL OF HEADACHE AND PAIN

SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates

(2020) Gregory A Poland et al.   LANCET

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

(2020) Evan J. Anderson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Relationship of Migraine and Tension‐Type Headache With Hypothyroidism: A Literature Review

(2019) Ioanna Spanou et al.   HEADACHE

Hypothalamic regulation of headache and migraine

(2019) Arne May et al.   CEPHALALGIA

Safety of the 9-Valent Human Papillomavirus Vaccine

(2019) Tom T. Shimabukuro et al.   PEDIATRICS

Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine

(2018) Stephanie F. James et al.   ANNALS OF PHARMACOTHERAPY

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

(2018)   CEPHALALGIA

Cognitive Performance and the Alteration of Neuroendocrine Hormones in Chronic Tension-Type Headache

(2017) Ping Qu et al.   Pain Practice

Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults

(2013) Stéphanie Pépin et al.   VACCINE

Immunological mechanisms of vaccination

(2011) Bali Pulendran et al.   NATURE IMMUNOLOGY

Kinetics of Serum Cytokines after Primary or Repeat Vaccination with the Smallpox Vaccine

(2010) Jeffrey I. Cohen et al.   JOURNAL OF INFECTIOUS DISEASES